The drug device combination products market involves medicinal products that combine both a pharmaceutical dosage form and a medical device into a single integrated product. The drug device combination products provide various advantages such as convenient dosing, improved treatment compliance and synchronization of the drug with the delivery device. Some key drug device combination products...
Drug device combination products are medical devices that are combined with pharmaceutical agents to serve both therapeutic and diagnostic purposes. They allow targeted, controlled and sustained release of drugs into the body either through oral, intravenous, intramuscular or transdermal delivery routes. Some key advantages of combination products include improved patient adherence and...
Drug device combination products refer to medical devices combined with drugs or biological products for the treatment, prevention, diagnosis or cure of diseases and conditions. Such products are manufactured to deliver biologics, drugs or other substances either systemically or locally in the body. For instance, inhalers deliver medicines directly to lungs for respiratory diseases, transdermal...
Market Dynamics: The growth of the drug device combination products market is majorly driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer. According to the World Health Organization (WHO), chronic diseases accounted for approximately 60% of all deaths globally in 2016. Furthermore, technological advancements in the field of drug delivery...